These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4012673)

  • 21. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis.
    Jones AJ; Meunier AM
    Thromb Haemost; 1990 Nov; 64(3):455-63. PubMed ID: 2128976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
    Sugiyama N; Iwamoto M; Abiko Y
    Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface.
    Hajjar KA; Nachman RL
    J Clin Invest; 1988 Nov; 82(5):1769-78. PubMed ID: 3141482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
    Aoki N; Moroi M; Tachiya K
    Thromb Haemost; 1978 Feb; 39(1):22-31. PubMed ID: 77050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.
    Suenson E; Lützen O; Thorsen S
    Eur J Biochem; 1984 May; 140(3):513-22. PubMed ID: 6233145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of fibrinolytic activity in bovine plasma by the combined effects of chloroform and dextran sulphate.
    Jenks RL; Kluft C; Astrup T
    Haemostasis; 1981; 10(2):108-18. PubMed ID: 6161866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
    Pannell R; Black J; Gurewich V
    J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration.
    Andrew M; Brooker L; Leaker M; Paes B; Weitz J
    Thromb Haemost; 1992 Sep; 68(3):325-30. PubMed ID: 1440499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the murine plasma fibrinolytic system.
    Lijnen HR; van Hoef B; Beelen V; Collen D
    Eur J Biochem; 1994 Sep; 224(3):863-71. PubMed ID: 7523120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The fibrinolytic action of the synthetic agent S-1623 in a purified system of fibrin and plasminogen.
    Chevallet-Prandini MH; Chapel A; Hudry-Clergeon G; Suscillon M
    Thromb Res; 1981 Nov; 24(3):197-205. PubMed ID: 6461088
    [No Abstract]   [Full Text] [Related]  

  • 33. Binding of 99mTc plasminogen on fibrin.
    Juhan-Vague I; Calas MF; Roux F; Juhan C; Durand-Dessemon F; de Laforte C; Serradimigni A
    Thromb Haemost; 1981 Apr; 45(2):154-7. PubMed ID: 6789493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma fibronectin enhances fibrinolytic system in vitro.
    Gilboa N; Kaplan JE
    Thromb Haemost; 1985 Oct; 54(3):639-44. PubMed ID: 2935966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue-type plasminogen activator increases the binding of glu-plasminogen to clots.
    Tran-Thang C; Kruithof EK; Bachmann F
    J Clin Invest; 1984 Dec; 74(6):2009-16. PubMed ID: 6210307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
    Rouy D; Anglés-Cano E
    Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basic principles in thrombolysis: regulatory role of plasminogen.
    Rijken DC; Sakharov DV
    Thromb Res; 2001 Sep; 103 Suppl 1():S41-9. PubMed ID: 11567668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical and biophysical conditions for blood clot lysis.
    Sabovic M; Blinc A
    Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basic mechanisms and regulation of fibrinolysis.
    Longstaff C; Kolev K
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S98-105. PubMed ID: 26149056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lytic resistance of fibrin containing red blood cells.
    Wohner N; Sótonyi P; Machovich R; Szabó L; Tenekedjiev K; Silva MM; Longstaff C; Kolev K
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2306-13. PubMed ID: 21737785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.